Colonoscopy Practice and Quality

• Audio chapter
  Single-voice audio, listen on the commute.
• ABIM-format MCQs
  5-option vignettes with full wrong-answer teaching.
• Study guide
  Tables, decision trees, primary sources.
• AI tutor
  Chapter-grounded, answers the question you're stuck on.

What this chapter covers

• Section 30.1: CRC screening modalities and USPSTF age update

  Screening policy (start at 45, the modality menu and intervals, the stop ages, and test performance) is covered in full in Section 15.1, and the high-risk start ages are in Ch 36.

• Section 30.2: Bowel preparation and procedural quality foundations

  Bowel preparation adequacy is the foundation on which every subsequent quality metric rests, because inadequate preparation roughly doubles polyp miss rates and detection technique cannot compensate for residual stool obscuring mucosa.

• Section 30.3: Detection metrics: ADR, SSLDR, withdrawal

  Adenoma detection rate is the single most validated quality metric in colonoscopy because its association with interval cancer is robust across populations.

• Section 30.4: Polyp recognition and morphology

  Polyp morphology drives both cancer risk assessment and resection technique selection, because morphology reflects the underlying growth pattern that determines whether a lesion has invaded vertically into the submucosa or spread horizontally along the mucosa.

• Section 30.5: Resection technique selection

  Resection technique is selected by polyp size, morphology, and cancer-risk features.

• Section 30.6: Malignant polyp management

  Pathology terminology in colorectal lesions is confusing and clinically consequential, and in malignant polyp management submucosal invasion, not mucosal involvement, is what carries metastatic potential.

• Section 30.7: 2020 USMSTF post-polypectomy surveillance intervals

  The 2020 US Multi-Society Task Force update on follow-up after colonoscopy and polypectomy drives interval selection from index findings, and the likelihood of metachronous advanced neoplasia within the surveillance window is calibrated to the highest-risk lesion at the index colonoscopy.

• Section 30.8: Post-polypectomy adverse events

  Post-polypectomy adverse events are recognizable, gradable, and largely manageable when caught early, and each event has a specific anatomic or thermal mechanism that determines management.

• Section 30.9: The serrated pathway and Lynch sorting

  The serrated pathway (BRAF V600E, CIMP-high, MLH1 promoter methylation) produces 15 to 30 percent of colorectal cancers; its biology is covered in Section 15.4 and the universal tumor testing algorithm for Lynch syndrome in Section 15.2.

• Section 30.10: Special-population colonoscopy

  Special populations modify all four phases of colonoscopy (preparation, sedation, intervention, recovery), and in each case the underlying physiology (pregnancy hemodynamics, cirrhotic coagulopathy, ESRD fluid and electrolyte vulnerability, antithrombotic exposure) determines which standard step has to be adjusted.

Podcast episodes

1. 01

   Colonoscopy Practice and Quality: Prep and Quality

   Colonoscopy protects patients only as far as its quality allows. The episode follows a man with a positive stool test, which shows that every positive non-invasive test leads to colonoscopy, with the commitment secured before the test is chosen. Preparation comes next: split dosing finished four to eight hours before the procedure, avoiding sodium phosphate and mannitol, and scoring with the Boston scale, where any segment under two makes the preparation inadequate. Completeness follows, shown by cecal photographs and a withdrawal time of at least eight minutes. A woman with an interval cancer then shows the endoscopist's own numbers: the adenoma detection rate, the serrated detection rate, and the techniques and tools that raise detection.

   Read the transcript →
2. 02

   Colonoscopy Practice and Quality: Shape and Snare

   The organizing idea is that a lesion is described before it is touched, because its shape and surface decide how it comes out. The episode starts with the Paris classification, then reads vessels and surface with NICE, JNET, and Kudo. It sets cancer risk by lateral spreading subtype and reviews serrated polyp recognition. It then matches the tool to the lesion: cold snare for small polyps, hot snare with a clip or loop for thick stalks, and EMR with a lift test for larger lesions. It closes with margin treatment, underwater EMR for scar, and when a lesion must come out in one piece by dissection.

   Read the transcript →
3. 03

   Colonoscopy Practice and Quality: Polyp Pathology

   Pathology decides two things after polypectomy: whether the patient needs surgery, and when to look again. The episode starts with why intramucosal adenocarcinoma in the colon is cured by complete resection, then describes invasion depth by Kikuchi or Haggitt level. It then covers the four high-risk features, any one of which sends a patient to surgery, and why deep invasion alone does not in a poor surgical candidate. Next come the 2020 surveillance intervals, set by the highest-risk lesion, and the separate schedule for a piecemeal resection site. It closes with MLH1 loss, where BRAF or methylation separates sporadic cancer from Lynch syndrome, and with serrated polyposis.

   Read the transcript →
4. 04

   Colonoscopy Practice and Quality: Adverse Events

   Each complication after polypectomy has its own anatomic or thermal mechanism, and that mechanism, along with the timing and location of symptoms, decides management. The episode starts with a woman on aspirin after a large cecal resection. It covers immediate versus delayed bleeding, which proximal defects benefit from clip closure, and how a perforation is handled depending on when it is found. It then turns to a man with fever after a hot snare whose CT shows no free air, which points to post-polypectomy syndrome. It closes with splenic injury after a difficult examination, then a symptom pattern review and the board traps.

   Read the transcript →
5. 05

   Colonoscopy Practice and Quality: Special Patients

   Special populations change the four phases of colonoscopy, preparation, sedation, intervention, and recovery, and the underlying physiology decides which standard step must change. The episode begins with a dialysis patient on apixaban: safe preparation, timing around dialysis, and an anticoagulant hold planned from the expected procedure. It then turns to cirrhosis, covering rectal varices, why INR should not drive transfusion, and sedation choices. Next comes pregnancy, with when colonoscopy proceeds and how it is done. It closes with a recent drug-eluting stent and when an elective polypectomy should wait, then reviews the board traps.

   Read the transcript →

Key topics

• ·Positive non-invasive test leads to colonoscopy
• ·Securing the colonoscopy commitment first
• ·Split-dose preparation timing
• ·Choosing and avoiding preparation agents
• ·Boston Bowel Preparation Scale
• ·Cecal intubation and withdrawal time
• ·Interval cancer and adenoma detection rate
• ·Serrated lesion detection rate
• ·Techniques and devices that raise detection
• ·Paris classification and invasion risk
• ·NICE, JNET, and Kudo optical diagnosis
• ·Lateral spreading lesion subtypes and cancer risk
• ·Choosing a technique by lesion type
• ·Serrated polyp recognition
• ·Cold snare versus forceps
• ·Hot snare for pedunculated polyps
• ·EMR and the non-lifting sign
• ·Margin treatment and underwater EMR
• ·Endoscopic submucosal dissection and curative criteria
• ·Intramucosal adenocarcinoma in the colon
• ·Kikuchi and Haggitt invasion depth
• ·Four high-risk histologic features
• ·Deep invasion in poor surgical candidates
• ·One-piece resection of suspicious lesions
• ·2020 surveillance intervals
• ·Serrated lesion intervals
• ·Piecemeal EMR site surveillance
• ·MLH1 loss and Lynch syndrome
• ·Serrated polyposis syndrome
• ·Post-polypectomy bleeding risk and aspirin